Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine

Trial Profile

Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine

Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2013

At a glance

  • Drugs Fludarabine (Primary) ; Thalidomide (Primary)
  • Indications Haematological malignancies
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 19 Jan 2007 Status changed from recruiting
    • 02 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top